[Possible mechanisms of inhibitory effects of atherosclerosis and lipoproteins on EDRF].
Hirata
K
K
First Department of Internal Medicine, Kobe University School of Medicine.
Akita
H
H
Inoue
N
N
Matsuda
Y
Y
Yokoyama
M
M
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001161:Arteriosclerosis / Q000209:etiology / Q000378:metabolism*; D001681:Biological Assay; D006801:Humans; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008244:Lysophosphatidylcholines / Q000378:metabolism; D009569:Nitric Oxide / Q000494:pharmacology / Q000502:physiology*; D010084:Oxidation-Reduction; D011817:Rabbits; D014664:Vasodilation / Q000187:drug effects
D007295:Inositol Phosphates; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008244:Lysophosphatidylcholines; D009569:Nitric Oxide; D000109:Acetylcholine